Home · Healthcare · VRTX
David M. Altshuler
Executive Officer · Vertex Pharmaceuticals (VRTX)
FY2023 Compensation
Total Compensation FY2023
$1.3M
As reported in 2024 DEF 14A proxy filing with the SEC
Compensation Breakdown
Base Salary
—
0% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
—
0% of total
Data Source: Compensation figures are sourced from Vertex Pharmaceuticals's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2023 as reported in the Summary Compensation Table.